CAPTRUST Financial Advisors
XENT

CAPTRUST Financial Advisors’s Intersect ENT, Inc XENT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-367
Closed -$10K – 5312
2022
Q1 		$10K Hold
367
– – ﹤0.01% 3834
2021
Q4 		$10K Buy
367
+26
+8% +$705 ﹤0.01% 3744
2021
Q3 		$9K Sell
341
-74
-18% -$1.83K ﹤0.01% 3702
2021
Q2 		$7K Sell
415
-777
-65% -$14.5K ﹤0.01% 3738
2021
Q1 		$25K Hold
1,192
– – ﹤0.01% 2874
2020
Q4 		$27K Sell
1,192
-6
-0.5% -$114 ﹤0.01% 2118
2020
Q3 		$19K Buy
1,198
+15
+1% +$272 ﹤0.01% 2004
2020
Q2 		$17K Buy
+1,183
New +$13.8K ﹤0.01% 2020
2019
Q3 		– Sell
-494
Closed -$11K – 2051
2019
Q2 		$11K Sell
494
-21
-4% -$566 ﹤0.01% 1488
2019
Q1 		$17K Buy
+515
New +$15.9K ﹤0.01% 1229

CAPTRUST Financial Advisors's XENT Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 367 shares — an estimated $10K sold.

CAPTRUST Financial Advisors first reported a position in XENT in Q1 2019 and held it in 10 quarters. The position peaked at $27K in Q4 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 367 Intersect ENT, Inc shares in Q2 2022, an estimated $10K.
  • CAPTRUST Financial Advisors first reported a position in Intersect ENT, Inc in Q1 2019 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Intersect ENT, Inc position peaked at $27K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.